Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEBO for Radiotherapy-Induced Mucositis
NCT06117904Completed
- Sponsor
- Beni Suef University
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Randomised, single-blind trial of MEBO Moist Burn Ointment in oral mucositis (OM) (2 arms), sponsored by Beni Suef University. Primary endpoint: Oral Mucositis Severity measured by WHO Toxicity Scale at 7 weeks. Started Jan 2024; status: completed.
02
Drugs
MEBO Moist Burn Ointment
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT06117904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06117904.